Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wisplinghoff

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Infection|June 6, 2012
Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignanciesB J Liss, J J Vehreschild, O A Cornely, et al.
Journal of Bone and Joint Infection|January 1, 2026
Effect of novel antimicrobial blue light-emitting optical fiber on vancomycin-resistant <i>Enterococcus faecium</i> and carbapenemase-producing <i>Klebsiella pneumoniae</i>Megan H Goh, Barbara Körber-Irrgang, Lucy L Hederick, et al.
The Journal of Infection|July 2, 2021
Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccinationLea Hsu, Hilmar Wisplinghoff, Annelene Kossow, et al.
The Journal of Infection|December 27, 2016
Determining vancomycin Etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobialsNina J Hos, Nathalie Jazmati, Danuta Stefanik, et al.
European Journal of Haematology|May 7, 2014
Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patientsMaria J G T Vehreschild, Michael von Bergwelt-Baildon, Liliane Tran, et al.
Mycoses|April 30, 2019
Mould-reactive T cells for the diagnosis of invasive mould infection-A prospective studyAngela Steinbach, Oliver A Cornely, Hilmar Wisplinghoff, et al.
Clinical Oral Investigations|January 24, 2024
The tongue microbiome of young patients with chronic kidney disease and their healthy mothersKarolin C Hoefer, Lutz T Weber, Anna Greta Barbe, et al.
The Journal of Antimicrobial Chemotherapy|April 23, 2010
Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohortJ J Vehreschild, M J G T Rüping, H Wisplinghoff, et al.
Plos One|January 14, 2022
Longitudinal variability in the urinary microbiota of healthy premenopausal women and the relation to neighboring microbial communities: A pilot studyLena M Biehl, Fedja Farowski, Catharina Hilpert, et al.
European Journal of Haematology|October 15, 2014
A cost and resource utilization analysis of micafungin bridging for hemato-oncological high-risk patients undergoing allogeneic stem cell transplantationSebastian M Heimann, Maria J G T Vehreschild, Oliver A Cornely, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Infection|June 6, 2012
Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignanciesB J Liss, J J Vehreschild, O A Cornely, et al.
Journal of Bone and Joint Infection|January 1, 2026
Effect of novel antimicrobial blue light-emitting optical fiber on vancomycin-resistant <i>Enterococcus faecium</i> and carbapenemase-producing <i>Klebsiella pneumoniae</i>Megan H Goh, Barbara Körber-Irrgang, Lucy L Hederick, et al.
The Journal of Infection|July 2, 2021
Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccinationLea Hsu, Hilmar Wisplinghoff, Annelene Kossow, et al.
The Journal of Infection|December 27, 2016
Determining vancomycin Etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobialsNina J Hos, Nathalie Jazmati, Danuta Stefanik, et al.
European Journal of Haematology|May 7, 2014
Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patientsMaria J G T Vehreschild, Michael von Bergwelt-Baildon, Liliane Tran, et al.
Mycoses|April 30, 2019
Mould-reactive T cells for the diagnosis of invasive mould infection-A prospective studyAngela Steinbach, Oliver A Cornely, Hilmar Wisplinghoff, et al.
Clinical Oral Investigations|January 24, 2024
The tongue microbiome of young patients with chronic kidney disease and their healthy mothersKarolin C Hoefer, Lutz T Weber, Anna Greta Barbe, et al.
The Journal of Antimicrobial Chemotherapy|April 23, 2010
Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohortJ J Vehreschild, M J G T Rüping, H Wisplinghoff, et al.
Plos One|January 14, 2022
Longitudinal variability in the urinary microbiota of healthy premenopausal women and the relation to neighboring microbial communities: A pilot studyLena M Biehl, Fedja Farowski, Catharina Hilpert, et al.
European Journal of Haematology|October 15, 2014
A cost and resource utilization analysis of micafungin bridging for hemato-oncological high-risk patients undergoing allogeneic stem cell transplantationSebastian M Heimann, Maria J G T Vehreschild, Oliver A Cornely, et al.
Pageof 11